159 related articles for article (PubMed ID: 12172572)
1. Markov model-based estimation of individual survival probability for medullary thyroid cancer patients.
Esik O; Tusnády G; Trón L; Boér A; Szentirmay Z; Szabolcs I; Rácz K; Lengyel E; Székely J; Kásler M
Pathol Oncol Res; 2002; 8(2):93-104. PubMed ID: 12172572
[TBL] [Abstract][Full Text] [Related]
2. Survival chance in papillary thyroid cancer in Hungary: individual survival probability estimation using the Markov method.
Esik O; Tusnády G; Daubner K; Németh G; Füzy M; Szentirmay Z
Radiother Oncol; 1997 Sep; 44(3):203-12. PubMed ID: 9380818
[TBL] [Abstract][Full Text] [Related]
3. [Survival potentials of patients with papillary carcinoma of the thyroid gland in Hungary].
Esik O; Tusnády G; Daubner K; Németh G; Füzy M; Szentirmay Z
Orv Hetil; 1996 May; 137(20):1067-78. PubMed ID: 8657418
[TBL] [Abstract][Full Text] [Related]
4. Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems.
Kebebew E; Ituarte PH; Siperstein AE; Duh QY; Clark OH
Cancer; 2000 Mar; 88(5):1139-48. PubMed ID: 10699905
[TBL] [Abstract][Full Text] [Related]
5. Surgical strategy for the treatment of sporadic medullary thyroid carcinoma: our experience.
Lupone G; Antonino A; Rosato A; Zenone P; Iervolino EM; Grillo M; De Palma M
G Chir; 2012; 33(11-12):395-9. PubMed ID: 23140924
[TBL] [Abstract][Full Text] [Related]
6. [PATHYPRE: Pascal program for the estimation of the individual course of patients with papillary thyroid cancer].
Esik O; Rejtó L; Tusnády G
Orv Hetil; 1997 Apr; 138(15):939-42. PubMed ID: 9173384
[TBL] [Abstract][Full Text] [Related]
7. Role of external beam radiotherapy in patients with advanced or recurrent nonanaplastic thyroid cancer: Memorial Sloan-kettering Cancer Center experience.
Terezakis SA; Lee KS; Ghossein RA; Rivera M; Tuttle RM; Wolden SL; Zelefsky MJ; Wong RJ; Patel SG; Pfister DG; Shaha AR; Lee NY
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):795-801. PubMed ID: 18676097
[TBL] [Abstract][Full Text] [Related]
8. Medullary thyroid cancer: clinico-pathological profile and outcome in a tertiary care center in North India.
Mehrotra PK; Mishra A; Mishra SK; Agarwal G; Agarwal A; Verma AK
World J Surg; 2011 Jun; 35(6):1273-80. PubMed ID: 21479684
[TBL] [Abstract][Full Text] [Related]
9. Prognostic variables and calcitonin in medullary thyroid cancer.
Clark JR; Fridman TR; Odell MJ; Brierley J; Walfish PG; Freeman JL
Laryngoscope; 2005 Aug; 115(8):1445-50. PubMed ID: 16094121
[TBL] [Abstract][Full Text] [Related]
10. Survival implications of cervical lymphadenectomy in patients with medullary thyroid cancer.
Kandil E; Gilson MM; Alabbas HH; Tufaro AP; Dackiw A; Tufano RP
Ann Surg Oncol; 2011 Apr; 18(4):1028-34. PubMed ID: 21046269
[TBL] [Abstract][Full Text] [Related]
11. Temporal Trends in the Presentation, Treatment, and Outcome of Medullary Thyroid Carcinoma: An Israeli Multicenter Study.
Hirsch D; Twito O; Levy S; Bachar G; Robenshtok E; Gross DJ; Mazeh H; Benbassat C; Grozinsky-Glasberg S
Thyroid; 2018 Mar; 28(3):369-376. PubMed ID: 29402183
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors for sporadic medullary thyroid carcinoma.
Gülben K; Berberoğlu U; Boyabatli M
World J Surg; 2006 Jan; 30(1):84-90. PubMed ID: 16369705
[TBL] [Abstract][Full Text] [Related]
13. Lymph node metastases and elevated postoperative calcitonin: Predictors of poor survival in medullary thyroid carcinoma.
Siironen P; Hagström J; Mäenpää HO; Louhimo J; Arola J; Haglund C
Acta Oncol; 2016; 55(3):357-64. PubMed ID: 26339947
[TBL] [Abstract][Full Text] [Related]
14. Postoperative radiotherapy for advanced medullary thyroid cancer--local disease control in the modern era.
Schwartz DL; Rana V; Shaw S; Yazbeck C; Ang KK; Morrison WH; Rosenthal DI; Hoff A; Evans DB; Clayman GL; Garden AS; Sherman SI
Head Neck; 2008 Jul; 30(7):883-8. PubMed ID: 18213725
[TBL] [Abstract][Full Text] [Related]
15. Prognostic influence of clinical and pathological factors in medullary thyroid carcinoma: a study of 53 cases.
Brandão LG; Cavalheiro BG; Junqueira CR
Clinics (Sao Paulo); 2009; 64(9):849-56. PubMed ID: 19759878
[TBL] [Abstract][Full Text] [Related]
16. Surgical management and follow-up of medullary thyroid carcinoma.
Marzano LA; Porcelli A; Biondi B; Lupoli G; Delrio P; Lombardi G; Zarrilli L
J Surg Oncol; 1995 Jul; 59(3):162-8. PubMed ID: 7609522
[TBL] [Abstract][Full Text] [Related]
17. Medullary thyroid cancer: multivariate analysis of prognostic factors influencing survival.
Hyer SL; Vini L; A'Hern R; Harmer C
Eur J Surg Oncol; 2000 Nov; 26(7):686-90. PubMed ID: 11187027
[TBL] [Abstract][Full Text] [Related]
18. [Therapeutic concepts and long-term outcome in thyroid gland carcinoma].
Linder R; Fuhrmann J; Hammerschmidt D
Zentralbl Chir; 1996; 121(6):459-64. PubMed ID: 8767331
[TBL] [Abstract][Full Text] [Related]
19. Medullary thyroid cancer: analyses of survival and prognostic factors and the role of radiation therapy in local control.
Brierley J; Tsang R; Simpson WJ; Gospodarowicz M; Sutcliffe S; Panzarella T
Thyroid; 1996 Aug; 6(4):305-10. PubMed ID: 8875751
[TBL] [Abstract][Full Text] [Related]
20. Medullary thyroid cancer: prognostic factors for survival and recurrence, recommendations for the extent of lymph node dissection and for surgical therapy in recurrent disease.
Pilaete K; Delaere P; Decallonne B; Bex M; Hauben E; Nuyts S; Clement P; Hermans R; Vander Poorten V
B-ENT; 2012; 8(2):113-21. PubMed ID: 22896930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
